Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Coherus Oncology, Inc.

Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Coherus Oncology to Participate in Upcoming Investor Conferences
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Coherus Oncology to Participate in Upcoming Investor Conferences
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025
From Coherus Oncology, Inc.
Via GlobeNewswire
Tickers CHRS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.